|
2014
|
Invention
|
Compounds and methods.
Disclosed are compounds having the formula:
Disclosed are compounds hav... |
|
2012
|
Invention
|
Therapeutic methods. The present invention relates to methods of treatment of diseases mediated b... |
|
|
Invention
|
Compounds and methods. Disclosed are compounds having the formula I, wherein Ar, n, Rx, k, X, m, ... |
|
|
Invention
|
Compounds and methods. Disclosed are compounds having the formula (I), wherein R1, R2, R3, and n ... |
|
|
Invention
|
Compounds and methods. Disclosed are compounds having the formula (I), wherein Ar, X, and R are a... |
|
|
Invention
|
Compounds and methods. The present invention relates to compounds that inhibit histone deacetylas... |
|
|
Invention
|
Compounds and methods to inhibit histone deacetylase (hdac) enzymes. The invention relates to com... |
|
|
Invention
|
Compounds and methods.
The present invention relates to novel retinoid-related orphan receptor g... |
|
|
Invention
|
Compounds and methods. The present invention relates to no vel retinoid-related orphan receptor g... |
|
|
Invention
|
Compounds and methods. The present invention relates to novel retinoid-reiated orphan receptor ga... |
|
|
Invention
|
Compounds and methods. The present invention relates to novel retinoid-related orphan receptor ga... |
|
|
Invention
|
Methods of treatment. Disclosed is a method of treating a neurodegenerative disease or disorder b... |
|
|
Invention
|
Methods of treatment. Disclosed is a method of treating a neurodegenerative disease or disorder o... |
|
|
Invention
|
Methods of treatment. Disclosed is a method of treating a B-cell lymphoma by administering a comp... |
|
|
Invention
|
Compounds and methods. Disclosed are compounds having formula I, wherein X1, X2, X3, R1, R2, R3, ... |
|
2011
|
Invention
|
Poised th17 cells, methods of isolation, and methods of use. Disclosed are isolated poised Th17 m... |
|
|
Invention
|
Compounds and methods. Disclosed are compounds having the formula:
4, Y, A, Z, L and n are as de... |
|
|
Invention
|
Oxadiazole hdac inhibitors. Disclosed are compounds having the formula:
2, Y, Q, X, B and L are ... |
|
|
Invention
|
Inhibitors of histone deacetylase (hdac) enzymes. Disclosed are compounds having the formula: whe... |
|
|
Invention
|
Compounds and methods. Disclosed are compounds having the formula: wherein X1, X2, X3, R1, R2, R3... |
|
|
Invention
|
Compounds and methods. Disclosed are compounds having the formula: wherein X1, X2, X3, R1, R2, Y,... |
